A synthetic peptide from aa region 150-200 of human RalA conjugated to blue carrier protein was used as the antigen. The antigen is homologous in rat and mouse.
rala
Reaktivität: Human
WB, IF
Wirt: Kaninchen
Polyclonal
unconjugated
Applikationshinweise
A concentration of 10-50 µg/ml is recommended. The optimal concentration should be determined by the end user. Not yet tested in other applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstitute in 100 µL of sterile water. Centrifuge to remove any insoluble material.
Handhabung
Avoid freeze and thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Maintain the lyophilised/reconstituted antibodies frozen at -20°C for long term storage and refrigerated at 2-8°C for a shorter term. When reconstituting, glycerol (1:1) may be added for an additional stability. Avoid freeze and thaw cycles.
3010001O15Rik antikoerper, AW322615 antikoerper, Ral antikoerper, Rasl1 antikoerper, RAL antikoerper, v-ral simian leukemia viral oncogene A (ras related) antikoerper, RAS like proto-oncogene A antikoerper, Rala antikoerper, RALA antikoerper
Hintergrund
The product of this gene belongs to the small GTPase superfamily, Ras family of proteins. GTP-binding proteins mediate thetransmembrane signaling initiated by the occupancy of certain cell surface receptors. This gene encodes a low molecular mass ras-like GTP-binding protein that shares about 50% similarity with other ras proteins. Subunit: Interacts with RALBP1 via its effector domain. Interacts with EXOC8 and EXOC2. EXOC2 and EXOC8 have overlapping binding sites and compete for RALA binding. Interacts with Clostridium exoenzyme C3. Interacts with RALGPS1. Subcellular location: Cell membrane, Lipid-anchor, Cytoplasmic side. Also known as: Rala, Ral, Ral-a, MGC48949.